Study of Fulvestrant +/- Everolimus in Post-Menopausal, Hormone-Receptor + Metastatic Breast Ca Resistant to AI
Clinical trial NCT01797120 · COMPLETED
Trial details
- NCT number
- NCT01797120
- Sponsor
- PrECOG, LLC.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-31
- Primary completion
- 2017-03-22
- Enrollment
- 131
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.